Crossmark

Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension

Crossref DOI link: https://doi.org/10.1007/s00408-017-0014-5

Published Online: 2017-05-17

Published Print: 2017-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wetzl, Veronika

Tiede, Svenja Lena

Faerber, Lothar

Weissmann, Norbert

Schermuly, Ralph Theo

Ghofrani, Hossein Ardeschir

Gall, Henning
Funding

Funding for this research was provided by:

Novartis Pharma (funding for research project)

Novartis Pharma (PhD thesis)
License Information

License valid from 2017-05-17